Excellium Pharmaceutical

Excellium Pharmaceutical is a generic pharmaceutical manufacturer based in Fairfield, New Jersey, specializing in the development and production of oral solid dosage forms. Founded in 1996, the company operates a 53,000 square foot FDA-approved facility and holds a DEA license for manufacturing Schedule III - V controlled substances. In December 2014, Excellium was acquired by Leading Pharma, LLC, and now serves as its primary in-house manufacturing and development center. The company holds numerous Abbreviated New Drug Applications (ANDAs) for products such as glycopyrrolate, benztropine mesylate, and lorazepam, and continues to expand its portfolio of difficult-to-formulate generic drugs.